See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $965B | 15.1x | 33.4x | |
| $617B | 6.6x | 17.3x | |
| $465B | 7.6x | 17.8x | |
| $335B | 5.9x | 14.2x | |
| $319B | 4.9x | 10.7x | |
| $243B | 6.7x | 13.8x | |
| $221B | 5.0x | 19.8x | |
| $206B | 7.1x | 12.9x | |
| $202B | 3.3x | 8.2x | |
| $166B | 6.8x | 21.7x | |
| $158B | 3.3x | 8.5x | |
| $137B | 3.1x | 9.2x | |
| $113B | 9.4x | 21.0x | |
| $92.2B | 1.7x | 8.1x | |
| $91.5B | 11.5x | 22.6x | |
| $83.0B | 2.9x | 10.6x | |
| $76.9B | 5.4x | 15.4x | |
| $75.8B | 3.0x | 10.5x | |
| $62.9B | 7.2x | 23.2x | |
| $62.3B | 6.6x | 15.1x | |
| $61.5B | 3.6x | 10.7x | |
| $50.1B | 10.5x | 34.8x | |
| $39.1B | 10.5x | 55.8x | |
| $31.7B | 2.3x | 7.7x | |
| $31.7B | 2.5x | 10.4x | |
| $28.8B | 2.6x | 13.1x | |
| $28.1B | 12.7x | -84.9x | |
| $26.7B | 9.0x | 9.2x | |
| $23.7B | 11.3x | 29.3x | |
| $22.1B | 6.2x | 20.5x | |
| $18.6B | 9.6x | 107.0x | |
| $17.2B | 6.4x | 26.6x | |
| $16.8B | 52.5x | n/a | |
| $13.8B | 3.1x | 8.1x | |
| $12.9B | 3.8x | 9.0x | |
| $12.5B | 13.9x | -33.8x | |
| $11.0B | 5.3x | 14.5x | |
| $10.6B | 3.4x | 14.4x | |
| $10.6B | 1.5x | 8.1x | |
| $10.2B | 4.4x | 10.8x | |
| $9.5B | 7.8x | 22.1x | |
| $9.4B | 485.2x | -14.0x | |
| $9.1B | 14.5x | -55.7x | |
| $8.8B | 1.4x | 11.0x | |
| $7.2B | 2.3x | 9.5x | |
| $7.1B | 18.3x | 42.3x | |
| $7.1B | 2.4x | 10.4x | |
| $6.9B | n/a | -16.8x | |
| $6.9B | 88.6x | 15509.8x | |
| $6.8B | 23.0x | 541.1x | |
| $6.4B | 2.2x | 6.0x | |
| $6.3B | 118.1x | -20.0x | |
| $6.2B | 6.9x | 24.0x | |
| $5.9B | n/a | n/a | |
| $5.7B | 11.7x | 38.6x | |
| $5.4B | n/a | -20.1x | |
| $5.4B | 3.8x | 11.4x | |
| $5.4B | 5.1x | 23.7x | |
| $5.3B | 6.3x | 31.8x | |
| $5.2B | 8.5x | 25.5x | |
| $5.1B | 1.4x | n/a | |
| $4.8B | 3.2x | 8.8x | |
| $4.6B | 7.6x | 33.5x | |
| $4.6B | 70.6x | -31.0x | |
| $4.5B | n/a | -8.8x | |
| $4.5B | n/a | -11.3x | |
| $4.4B | 4.7x | 13.0x | |
| $4.4B | 2.4x | 4.6x | |
| $4.3B | 3.5x | 14.0x | |
| $4.2B | 7.9x | 20.7x | |
| $4.1B | 5.8x | n/a | |
| $4.1B | 4.3x | 17.5x | |
| $3.9B | 3.0x | 16.7x | |
| $3.8B | n/a | n/a | |
| $3.8B | 2.2x | 10.8x | |
| $3.6B | 5.3x | 15.3x | |
| $3.3B | 12.7x | 31.4x | |
| $3.1B | n/a | n/a | |
| $3.0B | 367.5x | -5.3x | |
| $2.9B | 4.3x | 17.9x | |
| $2.9B | 3.3x | 13.2x | |
| $2.8B | 2.0x | 13.2x | |
| $2.8B | 2.7x | -21.5x | |
| $2.6B | 3.7x | 20.5x | |
| $2.4B | 4.0x | 13.0x | |
| $2.4B | 2.2x | 10.7x | |
| $2.3B | n/a | n/a | |
| $2.3B | 2.7x | 54.6x | |
| $2.2B | 8.5x | -1093.8x | |
| $2.2B | 5.1x | -80.4x | |
| $2.2B | 5.6x | 16.3x | |
| $2.2B | 1.7x | 9.0x | |
| $2.1B | 30.7x | -66.5x | |
| $2.1B | 9.4x | 35.8x | |
| $2.1B | 0.9x | 6.1x | |
| $1.9B | 1.7x | 12.5x | |
| $1.9B | 2.3x | 8.3x | |
| $1.8B | n/a | n/a | |
| $1.3B | 23.9x | -4.9x | |
| $1.2B | 2.8x | 8.9x |